Alumni Interview: Dr. Brandi MacDonald (Part 2)

In part two of our interview with Dr. Brandi MacDonald, Dr. MacDonald reflects on her career in archaeological science.

Interview with Stuart Koelewijn, Manager of Hot lab Operations at Quirem Medical, a Terumo company

We interviewed Stuart Koelewijn, Manager of Hot lab Operations at Quirem Medical, a Terumo company, about his career in nuclear medicine.

Alumni Interview: Dr. Brandi MacDonald (Part 1)

We interviewed McMaster graduate Dr. Brandi MacDonald about her research in archaeological science at McMaster Nuclear Reactor (MNR) and the University of Missouri Research Reactor (MURR).

Interview with a NO&F intern: Mymoon Bhuiyan

We interviewed McMaster engineering student Mymoon Bhuiyan about his internship at Nuclear Operations & Facilities, his research interests, and his role as Science Lead for the McMaster Mars Rover Team.

Nuclear Operations & Facilities hosts successful virtual radiological response exercise

On June 18th, 2021, McMaster University conducted a Type B drill to test McMaster Nuclear Reactor staff and Health Physics staff on their emergency response to a fire in a radiological area.

Bertram N. Brockhouse

Bertram Neville Brockhouse (1918-2003) was a Canadian physicist and a professor at McMaster University, where he advanced his work on neutron scattering.

Dr. Harry Thode

Henry George "Harry" Thode (1910-1997) was a Canadian nuclear chemist and President and Vice-Chancellor of McMaster University from 1961-1972.

New partnership focuses on life cycle management of Ontario’s power reactors

Building the McMaster Nuclear Reactor

The McMaster Nuclear Reactor (MNR) first became operational in 1959 and was the first university-based research reactor in the British Commonwealth. The construction took place between 1957-1959, and was well documented through a series of photographs. Take a look at the rich history of the McMaster Nuclear Reactor, and what it takes to make a research reactor!

Supplying the Globe with Medical Isotopes

In 2017, Nuclear Operations & Facilities responded to increased global demand for the essential medical isotope Iodine-125.